Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | AZN | AMGN | GILD | BMY |
| Company | Orphazyme A/S ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9060 | 196.55 | 344.09 | 133.69 | 59.40 |
| High | 0.9571 | 196.65 | 347.68 | 134.08 | 59.70 |
| Low | 0.8457 | 195.71 | 343.52 | 131.79 | 58.81 |
| Latest | 0.8700 | 195.69 | 344.44 | 132.02 | 58.73 |
| Change | -0.0200 | -0.09 | -0.42 | -1.27 | -0.66 |
| % Change | -2.25% | -0.05% | -0.12% | -0.95% | -1.11% |
| Volume | 941,400 | 672,353 | 447,269 | 2,038,287 | 2,292,260 |
| 20-Day Average Volume | 1,980,090 | 1,822,734 | 2,351,721 | 5,004,713 | 9,359,471 |
| Previous Close | 0.8900 | 195.78 | 344.86 | 133.29 | 59.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 198.83 | 349.54 | 138.19 | 59.17 |
| 20-Day Raw Stochastic | 41.76% | 53.41% | 41.71% | 6.17% | 32.87% |
| 20-Day Relative Strength | 36.52 | 48.57 | 44.31 | 38.01 | 49.65 |
| Weighted Alpha | -87.89 | +38.45 | +21.46 | +24.11 | +26.53 |
| Today's Opinion | 100% Sell | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 64% Buy | 24% Buy | 24% Buy | 64% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | -2.65% since 04/15/26 | -0.86% since 04/15/26 | -5.22% since 04/15/26 | +1.68% since 04/15/26 |
| Low | 0.8275 on 03/29/22 | 195.75 on 04/22/26 | 340.06 on 04/21/26 | 131.79 on 04/22/26 | 57.66 on 04/16/26 |
| High | 0.9600 on 03/29/22 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.26 on 04/16/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | +6.69% since 03/20/26 | -0.74% since 03/20/26 | -3.45% since 03/20/26 | +2.41% since 03/20/26 |
| Low | 0.5101 on 03/14/22 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.79 on 04/22/26 | 56.45 on 03/24/26 |
| High | 1.3720 on 03/10/22 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | +6.82% since 01/22/26 | -0.53% since 01/22/26 | +1.02% since 01/22/26 | +7.14% since 01/22/26 |
| Low | 0.5101 on 03/14/22 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.00 on 01/23/26 | 54.21 on 01/29/26 |
| High | 2.7500 on 01/03/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | +17.39% since 10/22/25 | +16.64% since 10/22/25 | +9.07% since 10/22/25 | +32.61% since 10/22/25 |
| Low | 0.5101 on 03/14/22 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 5.4900 on 10/13/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 303,636,768 | 186,115,760 | 165,442,480 | 121,258,640 |
| Shares Outstanding, K | 35,312 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -97,010,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.68 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/05/22 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.03 | 16.67 | 9.61 |